Insulin-like growth factor-1 suspended in hyaluronan improves cartilage and subchondral cancellous bone repair in osteoarthritis of temporomandibular joint.
This study sought to evaluate the effects of intra-articular injection of insulin-like growth factor-1 (IGF-1) suspended in hyaluronan (HA) on the cartilage and subchondral cancellous bone repair in osteoarthritis (OA) of the temporomandibular joint (TMJ). Disc perforation was performed bilaterally in rabbit TMJs to induce OA. Four groups of animals (n=12) received OA induction only, and either intra-articular HA injection alone, intra-articular IGF-1 injection alone, or a combination of HA and IGF-1 injection. All therapy was begun 4 weeks after OA induction. The animals were killed 12 or 24 weeks after the first injection, for histology and micro-CT examinations. Two additional animals were used as normal controls. Typical cartilage and subchondral cancellous bone lesions were observed in the OA group. No protective effect on cartilage and subchondral cancellous bone was found in the HA or IGF-1 alone groups. Better histological repair and nearly normal micro-architectural properties of the subchondral cancellous bone were observed in the HA+IGF-1 group compared with the HA or IGF-1 alone groups. HA may be used as an effective carrier for intra-articular injection of IGF-1 and the combination of HA/IGF-1 shows promise as a new rational approach to therapy of TMJ OA.
State Key Laboratory of Oral Diseases, Sichuan University, Chengdu, Sichuan, People's Republic of China.
X-W
XW
Liu
J
J
Hu
C
C
Man
B
B
Zhang
Y-Q
YQ
Ma
S-S
SS
Zhu
D000818:Animals; D001861:Bone Regeneration / Q000187:drug effects*; D020219:Chondrogenesis / Q000187:drug effects*; D004338:Drug Combinations; D006820:Hyaluronic Acid / Q000008:administration & dosage*; D007270:Injections, Intra-Articular; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage*; D010003:Osteoarthritis / Q000188:drug therapy*; D011817:Rabbits; D013705:Temporomandibular Joint Disorders / Q000188:drug therapy*; D055675:Viscosupplements / Q000008:administration & dosage*
D004338:Drug Combinations; D055675:Viscosupplements; D007334:Insulin-Like Growth Factor I; D006820:Hyaluronic Acid